医学
儿科
重症监护医学
益生菌
梅德林
临床试验
循证医学
替代医学
临床实习
儿童健康
作者
Maria Zemła,Maja Kotowska-Bąbol,Hania Szajewska
标识
DOI:10.1097/mco.0000000000001192
摘要
Recent trials have not provided sufficient evidence to justify changes to the ESPGHAN recommendations. Evidence for probiotic use in paediatrics is confined to a few strains and indications. Larger multicentre studies with standardised preparations and clearly defined outcomes are still needed.
科研通智能强力驱动
Strongly Powered by AbleSci AI